Prospera Biotech — Seed (estimated) · approximately €625K

Prospera Biotech raised more than €625,000 from 145 investors through the Capital Cell equity crowdfunding platform. The round opened in March 2023 with a €600,000 target and had passed €500K by early May. The money pays for an international multi-centre clinical trial of Oncapsisens for chemotherapy-induced skin discomfort in 15 Spanish and European hospitals, and for expanding the company abroad. Crunchbase lists it as a Seed round of about $653K dated 24 March 2023, which is the day the campaign opened. The company has also had public grants, including an AVI/FEDER collaboration project worth €91,620, and support from Parque Científico UMH. Neither is counted as a round.